355 related articles for article (PubMed ID: 35385798)
1. Electronic Alerts to Improve Heart Failure Therapy in Outpatient Practice: A Cluster Randomized Trial.
Ghazi L; Yamamoto Y; Riello RJ; Coronel-Moreno C; Martin M; O'Connor KD; Simonov M; Huang J; Olufade T; McDermott J; Dhar R; Inzucchi SE; Velazquez EJ; Wilson FP; Desai NR; Ahmad T
J Am Coll Cardiol; 2022 Jun; 79(22):2203-2213. PubMed ID: 35385798
[TBL] [Abstract][Full Text] [Related]
2. Rationale and design of a cluster-randomized pragmatic trial aimed at improving use of guideline directed medical therapy in outpatients with heart failure: PRagmatic trial of messaging to providers about treatment of heart failure (PROMPT-HF).
Ghazi L; Desai NR; Simonov M; Yamamoto Y; O'Connor KD; Riello RJ; Huang J; Olufade T; McDermott J; Inzucchi SE; Velazquez EJ; Wilson FP; Ahmad T
Am Heart J; 2022 Feb; 244():107-115. PubMed ID: 34808104
[TBL] [Abstract][Full Text] [Related]
3. Electronic health record alerts for management of heart failure with reduced ejection fraction in hospitalized patients: the PROMPT-AHF trial.
Ghazi L; Yamamoto Y; Fuery M; O'Connor K; Sen S; Samsky M; Riello RJ; Dhar R; Huang J; Olufade T; McDermott J; Inzucchi SE; Velazquez EJ; Wilson FP; Desai NR; Ahmad T
Eur Heart J; 2023 Oct; 44(40):4233-4242. PubMed ID: 37650264
[TBL] [Abstract][Full Text] [Related]
4. Pragmatic trial of messaging to providers about treatment of acute heart failure: The PROMPT-AHF trial.
Ghazi L; O'Connor K; Yamamoto Y; Fuery M; Sen S; Samsky M; Riello RJ; Huang J; Olufade T; McDermott J; Inzucchi SE; Velazquez EJ; Wilson FP; Desai NR; Ahmad T
Am Heart J; 2023 Mar; 257():111-119. PubMed ID: 36493842
[TBL] [Abstract][Full Text] [Related]
5. Cluster-Randomized Trial Comparing Ambulatory Decision Support Tools to Improve Heart Failure Care.
Mukhopadhyay A; Reynolds HR; Phillips LM; Nagler AR; King WC; Szerencsy A; Saxena A; Aminian R; Klapheke N; Horwitz LI; Katz SD; Blecker S
J Am Coll Cardiol; 2023 Apr; 81(14):1303-1316. PubMed ID: 36882134
[TBL] [Abstract][Full Text] [Related]
6. Remote Optimization of Guideline-Directed Medical Therapy in Patients With Heart Failure With Reduced Ejection Fraction.
Desai AS; Maclean T; Blood AJ; Bosque-Hamilton J; Dunning J; Fischer C; Fera L; Smith KV; Wagholikar K; Zelle D; Gaziano T; Plutzky J; Scirica B; MacRae CA
JAMA Cardiol; 2020 Dec; 5(12):1430-1434. PubMed ID: 32936209
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of medical therapy in patients with heart failure with reduced ejection fraction.
Kocabaş U; Ergin I; Kıvrak T; Yılmaz Öztekin GM; Tanık VO; Özdemir İ; Avcı Demir F; Doğduş M; Şen T; Altınsoy M; Üstündağ S; Urgun ÖD; Sinan ÜY; Uygur B; Yeni M; Özçalık E
ESC Heart Fail; 2023 Dec; 10(6):3677-3689. PubMed ID: 37804042
[TBL] [Abstract][Full Text] [Related]
8. Background pharmacological therapy in the ANTHEM-HF: comparison to contemporary trials of novel heart failure therapies.
Premchand RK; Sharma K; Mittal S; Monteiro R; Libbus I; Ardell JL; Gregory DD; KenKnight BH; Amurthur B; DiCarlo LA; Anand IS
ESC Heart Fail; 2019 Oct; 6(5):1052-1056. PubMed ID: 31339232
[TBL] [Abstract][Full Text] [Related]
9. Frailty and uptake of angiotensin receptor neprilysin inhibitor for heart failure with reduced ejection fraction.
Lee YC; Lin JK; Ko D; Cheng S; Patorno E; Glynn RJ; Tsacogianis T; Kim DH
J Am Geriatr Soc; 2023 Oct; 71(10):3110-3121. PubMed ID: 37345734
[TBL] [Abstract][Full Text] [Related]
10. Rationale, Design, and Patient Characteristics of a Cluster-Randomized Pragmatic Trial to Improve Mineralocorticoid Antagonist Use.
Clark KAA; Victoria-Castro AM; Ghazi L; Yamamoto Y; Coronel-Moreno C; Kadhim BA; Riello RJ; O'Connor K; Ahmad T; Wilson FP; Desai NR
JACC Heart Fail; 2024 Feb; 12(2):322-332. PubMed ID: 37943221
[TBL] [Abstract][Full Text] [Related]
11. Prescription Rates and Prognostic Implications of Optimally Targeted Guideline-Directed Medical Treatment in Heart Failure and Atrial Fibrillation: Insights From The MISOAC-AF Trial.
Moysidis DV; Kartas A; Samaras A; Papazoglou AS; Patsiou V; Bekiaridou A; Baroutidou A; Tsagkaris C; Karagiannidis E; Daios S; Anastasiou V; Tsalikakis D; Efthimiadis G; Ziakas A; Tzikas A; Giannakoulas G
J Cardiovasc Pharmacol; 2023 Mar; 81(3):203-211. PubMed ID: 36626410
[TBL] [Abstract][Full Text] [Related]
12. Sex Disparities in Longitudinal Use and Intensification of Guideline-Directed Medical Therapy Among Patients With Newly Diagnosed Heart Failure With Reduced Ejection Fraction.
Sumarsono A; Xie L; Keshvani N; Zhang C; Patel L; Alonso WW; Thibodeau JT; Fonarow GC; Van Spall HGC; Messiah SE; Pandey A
Circulation; 2024 Feb; 149(7):510-520. PubMed ID: 38258605
[TBL] [Abstract][Full Text] [Related]
13. Polypharmacy and Optimization of Guideline-Directed Medical Therapy in Heart Failure: The GUIDE-IT Trial.
Khan MS; Singh S; Segar MW; Usman MS; Keshvani N; Ambrosy AP; Fiuzat M; Van Spall HGC; Fonarow GC; Zannad F; Felker GM; Januzzi JL; O'Connor C; Butler J; Pandey A
JACC Heart Fail; 2023 Nov; 11(11):1507-1517. PubMed ID: 37115133
[TBL] [Abstract][Full Text] [Related]
14. Contemporary Use of Sodium-Glucose Cotransporter-2 Inhibitor Therapy Among Patients Hospitalized for Heart Failure With Reduced Ejection Fraction in the US: The Get With The Guidelines-Heart Failure Registry.
Pierce JB; Vaduganathan M; Fonarow GC; Ikeaba U; Chiswell K; Butler J; DeVore AD; Heidenreich PA; Huang JC; Kittleson MM; Joynt Maddox KE; Linganathan KK; McDermott JJ; Owens AT; Peterson PN; Solomon SD; Vardeny O; Yancy CW; Greene SJ
JAMA Cardiol; 2023 Jul; 8(7):652-661. PubMed ID: 37212192
[TBL] [Abstract][Full Text] [Related]
15. Mortality and guideline-directed medical therapy in real-world heart failure patients with reduced ejection fraction.
McCullough PA; Mehta HS; Barker CM; Van Houten J; Mollenkopf S; Gunnarsson C; Ryan M; Cork DP
Clin Cardiol; 2021 Sep; 44(9):1192-1198. PubMed ID: 34342033
[TBL] [Abstract][Full Text] [Related]
16. Impact of Visit Volume on the Effectiveness of Electronic Tools to Improve Heart Failure Care.
Mukhopadhyay A; Reynolds HR; King WC; Phillips LM; Nagler AR; Szerencsy A; Saxena A; Klapheke N; Katz SD; Horwitz LI; Blecker S
JACC Heart Fail; 2024 Apr; 12(4):665-674. PubMed ID: 38043045
[TBL] [Abstract][Full Text] [Related]
17. Virtual optimization of guideline-directed medical therapy in hospitalized patients with heart failure with reduced ejection fraction: the IMPLEMENT-HF pilot study.
Bhatt AS; Varshney AS; Nekoui M; Moscone A; Cunningham JW; Jering KS; Patel PN; Sinnenberg LE; Bernier TD; Buckley LF; Cook BM; Dempsey J; Kelly J; Knowles DM; Lupi K; Malloy R; Matta LS; Rhoten MN; Sharma K; Snyder CA; Ting C; McElrath EE; Amato MG; Alobaidly M; Ulbricht CE; Choudhry NK; Adler DS; Vaduganathan M
Eur J Heart Fail; 2021 Jul; 23(7):1191-1201. PubMed ID: 33768599
[TBL] [Abstract][Full Text] [Related]
18. Differences in provider approach to initiating and titrating guideline directed medical therapy in heart failure with reduced ejection fraction.
Cordwin DJ; Guidi J; Alhashimi L; Hummel SL; Koelling TM; Dorsch MP
BMC Cardiovasc Disord; 2024 May; 24(1):247. PubMed ID: 38730379
[TBL] [Abstract][Full Text] [Related]
19. Assessment of Limitations to Optimization of Guideline-Directed Medical Therapy in Heart Failure From the GUIDE-IT Trial: A Secondary Analysis of a Randomized Clinical Trial.
Fiuzat M; Ezekowitz J; Alemayehu W; Westerhout CM; Sbolli M; Cani D; Whellan DJ; Ahmad T; Adams K; Piña IL; Patel CB; Anstrom KJ; Cooper LS; Mark D; Leifer ES; Felker GM; Januzzi JL; O'Connor CM
JAMA Cardiol; 2020 Jul; 5(7):757-764. PubMed ID: 32319999
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of Guideline-Directed Medical Therapy in Heart Failure Patients With and Without Chronic Kidney Disease: A Meta-Analysis of 63,677 Patients.
Clark KM; Mahboob F; Evans J; Sun JH; Wang N
Heart Lung Circ; 2024 Mar; 33(3):281-291. PubMed ID: 38365495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
